vs

Side-by-side financial comparison of Consolidated Edison (ED) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.

Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $4.0M, roughly 1.4× Consolidated Edison). On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 8.9%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -96.5%).

Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc.

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

ED vs TSHA — Head-to-Head

Bigger by revenue
TSHA
TSHA
1.4× larger
TSHA
$5.5M
$4.0M
ED
Growing faster (revenue YoY)
TSHA
TSHA
+162.4% gap
TSHA
171.3%
8.9%
ED
Faster 2-yr revenue CAGR
TSHA
TSHA
Annualised
TSHA
26.8%
-96.5%
ED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ED
ED
TSHA
TSHA
Revenue
$4.0M
$5.5M
Net Profit
$-27.9M
Gross Margin
Operating Margin
12.2%
-516.0%
Net Margin
-507.8%
Revenue YoY
8.9%
171.3%
Net Profit YoY
-48.3%
EPS (diluted)
$0.82
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ED
ED
TSHA
TSHA
Q1 26
$4.0M
Q4 25
$4.0B
$5.5M
Q3 25
$4.6B
$0
Q2 25
$3.6B
$2.0M
Q1 25
$4.9B
$2.3M
Q4 24
$3.7B
$2.0M
Q3 24
$4.2B
$1.8M
Q2 24
$3.3B
$1.1M
Net Profit
ED
ED
TSHA
TSHA
Q1 26
Q4 25
$298.0M
$-27.9M
Q3 25
$688.0M
$-32.7M
Q2 25
$246.0M
$-26.9M
Q1 25
$791.0M
$-21.5M
Q4 24
$310.0M
$-18.8M
Q3 24
$588.0M
$-25.5M
Q2 24
$202.0M
$-20.9M
Operating Margin
ED
ED
TSHA
TSHA
Q1 26
12.2%
Q4 25
12.3%
-516.0%
Q3 25
21.2%
Q2 25
9.8%
-1347.1%
Q1 25
23.0%
-930.5%
Q4 24
13.0%
-985.8%
Q3 24
20.4%
-1448.4%
Q2 24
9.7%
-1915.4%
Net Margin
ED
ED
TSHA
TSHA
Q1 26
Q4 25
7.5%
-507.8%
Q3 25
15.1%
Q2 25
6.8%
-1353.6%
Q1 25
16.2%
-935.2%
Q4 24
8.5%
-929.0%
Q3 24
13.9%
-1427.5%
Q2 24
6.1%
-1882.0%
EPS (diluted)
ED
ED
TSHA
TSHA
Q1 26
$0.82
Q4 25
$0.81
$-0.08
Q3 25
$1.90
$-0.09
Q2 25
$0.68
$-0.09
Q1 25
$2.25
$-0.08
Q4 24
$0.89
$-0.07
Q3 24
$1.69
$-0.10
Q2 24
$0.58
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ED
ED
TSHA
TSHA
Cash + ST InvestmentsLiquidity on hand
$319.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$246.9M
Total Assets
$343.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ED
ED
TSHA
TSHA
Q1 26
Q4 25
$1.6B
$319.8M
Q3 25
$181.0M
$297.3M
Q2 25
$1.5B
$312.8M
Q1 25
$360.0M
$116.6M
Q4 24
$1.3B
$139.0M
Q3 24
$93.0M
$157.7M
Q2 24
$1.5B
$172.7M
Total Debt
ED
ED
TSHA
TSHA
Q1 26
Q4 25
$25.8B
Q3 25
Q2 25
Q1 25
Q4 24
$24.7B
Q3 24
Q2 24
Stockholders' Equity
ED
ED
TSHA
TSHA
Q1 26
Q4 25
$24.2B
$246.9M
Q3 25
$24.2B
$219.0M
Q2 25
$23.8B
$248.7M
Q1 25
$23.8B
$55.1M
Q4 24
$22.0B
$71.5M
Q3 24
$21.9B
$88.8M
Q2 24
$21.6B
$108.9M
Total Assets
ED
ED
TSHA
TSHA
Q1 26
Q4 25
$74.6B
$343.3M
Q3 25
$71.8B
$316.6M
Q2 25
$71.5B
$333.3M
Q1 25
$70.7B
$138.4M
Q4 24
$70.6B
$160.4M
Q3 24
$68.6B
$180.2M
Q2 24
$67.9B
$200.4M
Debt / Equity
ED
ED
TSHA
TSHA
Q1 26
Q4 25
1.07×
Q3 25
Q2 25
Q1 25
Q4 24
1.13×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ED
ED
TSHA
TSHA
Operating Cash FlowLast quarter
$-26.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ED
ED
TSHA
TSHA
Q1 26
Q4 25
$1.5B
$-26.7M
Q3 25
$504.0M
$-24.2M
Q2 25
$2.0B
$-20.2M
Q1 25
$837.0M
$-22.0M
Q4 24
$1.3B
$-18.3M
Q3 24
$392.0M
$-21.6M
Q2 24
$1.3B
$-21.5M
Free Cash Flow
ED
ED
TSHA
TSHA
Q1 26
Q4 25
Q3 25
$-24.3M
Q2 25
Q1 25
Q4 24
$-18.3M
Q3 24
$-21.6M
Q2 24
$-21.7M
FCF Margin
ED
ED
TSHA
TSHA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-905.5%
Q3 24
-1210.9%
Q2 24
-1951.9%
Capex Intensity
ED
ED
TSHA
TSHA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.1%
Q3 24
2.0%
Q2 24
18.1%
Cash Conversion
ED
ED
TSHA
TSHA
Q1 26
Q4 25
4.97×
Q3 25
0.73×
Q2 25
8.04×
Q1 25
1.06×
Q4 24
4.23×
Q3 24
0.67×
Q2 24
6.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ED
ED

Electric$2.9M72%
Gas$923.0K23%
Other$187.0K5%
Non-utility$1.0K0%

TSHA
TSHA

Segment breakdown not available.

Related Comparisons